| Schedule of Investments Held |
The following table summarizes the Company’s investments: | | | | | | | | | | | | | | | | | | | | | | | | | As of | | Percentage of total investments as of | | | | | | March 31, | | December 31, | | March 31, | | December 31, | | 2026 | | 2025 | | 2026 | | 2025 | | Equity method investments | | | | | | | | Equity method - carried interest(1) | $ | 4,029,460 | | | $ | 3,972,748 | | | 73.0% | | 72.1% | | Equity method private investment partnership interests - principal | 522,078 | | | 526,372 | | | 9.5 | | 9.6 | | Equity method private investment partnership interests and other (held at fair value) | 671,522 | | | 675,777 | | | 12.2 | | 12.3 | | Equity method private investment partnership interests and other | 58,033 | | | 61,306 | | | 1.0 | | 1.1 | | Total equity method investments | 5,281,093 | | | 5,236,203 | | | 95.7 | | 95.1 | | Collateralized loan obligations | 11,112 | | | 13,217 | | | 0.2 | | 0.2 | | Fixed income securities | 11,701 | | | 11,252 | | | 0.2 | | 0.2 | | Collateralized loan obligations and fixed income securities, at fair value | 22,813 | | | 24,469 | | | 0.4 | | 0.4 | | Common stock and other equity securities, at fair value | 215,771 | | | 247,775 | | | 3.9 | | 4.5 | | Total investments | $ | 5,519,677 | | | $ | 5,508,447 | | | | | |
(1)Includes carried interest held at fair value of $64.0 million and $118.1 million as of March 31, 2026 and December 31, 2025, respectively. The following table summarizes investments held in the Consolidated Funds: | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value as of | | Percentage of total investments as of | | | | | | March 31, | | December 31, | | March 31, | | December 31, | | 2026 | | 2025 | | 2026 | | 2025 | | Fixed income investments | | | | | | | | | Loans and securitization vehicles | $ | 4,636,142 | | | $ | 5,507,199 | | | 36.4% | | 42.9% | | | | | | | | | | Bonds | 249,966 | | | 280,911 | | | 2.0 | | 2.2 | | Total fixed income investments | 4,886,108 | | | 5,788,110 | | | 38.4 | | 45.1 | | Partnership interests | 4,139,766 | | | 3,791,056 | | | 32.6 | | 29.6 | | Equity securities | 3,683,146 | | | 3,265,720 | | | 29.0 | | 25.4 | | Total investments, at fair value | $ | 12,709,020 | | | $ | 12,844,886 | | | | | |
|
| Schedule of Equity Method Investments |
The following table presents the Company’s share of net investment income and net realized and unrealized gains from its equity method investments, which are included within principal investment income, net realized and unrealized gains on investments, and interest and dividend income within the Condensed Consolidated Statements of Operations: | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended March 31, | | | | | | | 2026 | | 2025 | | | | Total net investment income and net realized and unrealized gains related to equity method investments | | | | | | $ | 33,584 | | | $ | 30,964 | | | |
The following table summarizes the changes in fair value of the Company’s equity method investments held at fair value, which are included within net realized and unrealized gains on investments within the Condensed Consolidated Statements of Operations: | | | | | | | | | | | | | | | | | | | | | | | Three months ended March 31, | | | | | | 2026 | | 2025 | | | | Equity method private investment partnership interests and other (held at fair value) | | | | | $ | 33,659 | | | $ | 4,281 | | | |
|